Novel Uveal Melanoma Patient-Derived Organoid Models Recapitulate Human Disease to Support Translational Research
Investigative Ophthalmology & Visual Science · 2024-11-27 · 65 (13) · 60
DOI: 10.1167/iovs.65.13.60 ↗At a glance
Multizentrische Studie in Investigative Ophthalmology & Visual Science, published on 2024-11-27. Written by Lauren A Dalvin and 20 co-authors. Institution: Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States. Major MEDLINE topics: Uveal Neoplasms, Organoids, Melanoma, Translational Research, Biomedical. Cited 11 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NCATS NIH HHS, NCI NIH HHS.
Abstract (original language)
Purpose
A lack of representative human disease models has limited the translation of new and more effective treatments in uveal melanoma (UM), the most common primary adult intraocular malignancy. To fill this critical need, we developed and characterized a multicenter biobank of UM patient-derived organoids (PDOs).
Methods
UM patients requiring enucleation from 2019 to 2024 donated tumor tissue for PDO generation. PDOs were cultured in Cultrex and compared to donor primary tumor using exome sequencing, RNA sequencing, and immunohistochemistry. The ability of PDOs to maintain the transformed phenotype was evaluated in an orthotopic xenograft model and monitored with fundus imaging. ATAC sequencing and drug response assays were done in a subset of PDOs to explore the feasibility of their use for mechanistic and translational studies.
Results
PDOs were successfully established in 40 of 44 cases (91%), retained clinically relevant mutations and molecular markers from the primary tumor, and displayed similar gene expression profiles and well-validated clinical prognostic markers of the disease. PDOs retained tumorigenic capacity in an in vivo model resembling human disease progression. Finally, we demonstrated that PDOs were a feasible platform to identify and evaluate novel therapeutic targets and investigate differential, personalized drug response.
Conclusions
PDO models offer a new platform with improved representation of human UM to aid in translational research for this dismal condition.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States.
- Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, United States.
- School of Medicine, Deakin University, Geelong, Victoria, Australia.
- Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Victoria, Australia.
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States.
Funding
- NCATS NIH HHS
- NCI NIH HHS
Cite
APA
Dalvin, L. A., Andrews-Pfannkoch, C. M., Miley, D. R., Hogenson, T. L., Erickson, S. A., Malpotra, S., Anderson, K. J., Omer, M. E., Almada, L. L., Zhang, C., Li, H., Salomao, D. R., Shields, C. L., Lally, S. E., Malsch, R. M., Armitage, J. A., Holmes, H. L., Romero, M. F., Fautsch, M. P., …, & Fernandez-Zapico, M. E. (2024). Novel Uveal Melanoma Patient-Derived Organoid Models Recapitulate Human Disease to Support Translational Research. Investigative Ophthalmology & Visual Science, 65(13), 60. https://doi.org/10.1167/iovs.65.13.60
Vancouver
Dalvin LA, Andrews-Pfannkoch CM, Miley DR, Hogenson TL, Erickson SA, Malpotra S, et al. Novel Uveal Melanoma Patient-Derived Organoid Models Recapitulate Human Disease to Support Translational Research. Investigative Ophthalmology & Visual Science. 2024;65(13):60. doi:10.1167/iovs.65.13.60
BibTeX
@article{Dalvin2024,
author = {Dalvin, Lauren A and Andrews-Pfannkoch, Cynthia M and Miley, David R and Hogenson, Tara L and Erickson, Samantha A and Malpotra, Shivani and Anderson, Kjersten J and Omer, Mohammed E and Almada, Luciana L and Zhang, Cheng and Li, Hu and Salomao, Diva R and Shields, Carol L and Lally, Sara E and Malsch, Rachel M and Armitage, James A and Holmes, Heather L and Romero, Michael F and Fautsch, Michael P and Markovic, Svetomir N and Fernandez-Zapico, Martin E},
title = {Novel Uveal Melanoma Patient-Derived Organoid Models Recapitulate Human Disease to Support Translational Research},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
volume = {65},
number = {13},
pages = {60},
doi = {10.1167/iovs.65.13.60}
}
EUVIMED